Citalopram Tablets

Healthy Inc is a specialized global supplier and exporter of advanced psychiatry, neuro-pharmacology, and targeted mood-stabilizing therapeutics. We provide ultra-high-purity, kinetically precise Citalopram Hydrobromide Film-Coated Tablets (10 mg / 20 mg / 40 mg), manufactured in WHO–GMP certified, high-precision oral solid dosage facilities. This “Selective Serotonin Reuptake Inhibitor (SSRI)” is a massive-volume, highly strategic export to psychiatric hospitals, community mental health networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, first-line intervention for Major Depressive Disorder (MDD) and Panic Disorder.


Product Overview

This formulation operates as a highly specific neurological stabilizer. It is recognized as one of the most “selective” SSRIs available, meaning it has minimal impact on norepinephrine or dopamine, resulting in fewer side effects like agitation or insomnia compared to older antidepressants.

The “Selective Serotonin & Minimal Interaction” Specialist:

  • Mechanism 1 (The SERT Blockade): Citalopram binds with extreme affinity to the Serotonin Transporter (SERT) on the pre-synaptic neuron. By physically blocking this “recycling” pump, the drug forces serotonin to remain in the synaptic cleft for longer periods. This persistent stimulation of the post-synaptic receptors fundamentally repairs the chemical imbalance driving clinical depression.
  • Mechanism 2 (High Receptor Selectivity): Unlike tricyclic antidepressants, Citalopram has virtually no affinity for histamine, acetylcholine, or alpha-adrenergic receptors. This translates to an Absolute Low Side-Effect Profile—no dry mouth, no blurred vision, and significantly less sedation, making it the preferred choice for elderly patients and active professionals.
  • Mechanism 3 (Minimal Drug-Drug Interactions): Citalopram has a very low potential for inhibiting the liver’s Cytochrome P450 enzymes. This makes it the “Pharmacist’s Choice” for patients already taking multiple medications for blood pressure or diabetes, as it is unlikely to cause toxic spikes in their other drugs.

Technical & Logistics Specifications

HS Code3004.90.99 (Medicaments containing other active substances – Psychiatry/Antidepressants)
CAS Number59729-33-8 (Citalopram) / 59729-32-7 (Citalopram HBr)
Dosage FormFilm-Coated Tablet (Immediate Gastric Release)
PackagingAlu-PVC or Alu-Alu Blisters. Protects the formulation from environmental humidity across Zone IVb tropical climates.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

  • API Purity & Impurity Profiling (CRITICAL COMPLIANCE): The synthesis of Citalopram must be strictly controlled to prevent the formation of toxic byproduct isomers. Our CNS suites utilize advanced HPLC and chiral chromatography to guarantee 100% isomeric purity. We provide global buyers with a product that delivers consistent, predictable blood levels without the “peaks and valleys” of lower-quality generics.

Therapeutic Indications

  • Major Depressive Disorder (MDD): Treatment of the acute phase and prevention of relapse.
  • Panic Disorder: Treatment with or without agoraphobia.
  • Obsessive-Compulsive Disorder (OCD): High-dose management of intrusive thoughts and repetitive behaviors.

Dosage & Administration

  • Standard Adult Dosing: Initially 20 mg once daily, increased to 40 mg if necessary.
  • The 40mg Ceiling (CRITICAL): The dose MUST NOT exceed 40 mg per day due to the risk of dose-dependent QTc prolongation.
  • Geriatric Dosing: In patients over 65, the maximum dose is strictly limited to 20 mg per day.

Safety Warnings (CRITICAL):

  • BLACK BOX WARNING (Suicidal Ideation): Increased risk of suicidal thinking in children, adolescents, and young adults (under 24) during early treatment.
  • QTc Prolongation: Can cause life-threatening heart rhythm changes. Avoid in patients with congenital long QT syndrome or those taking other QT-prolonging drugs.
  • Serotonin Syndrome: Risk increases if taken with MAOIs, Triptans, or St. John’s Wort.
  • Discontinuation Syndrome: Abrupt stopping causes “brain zaps,” dizziness, and irritability. Doses must be tapered slowly.

Global Export & Contract Manufacturing Services

Healthy Inc is a premier Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for SSRIs and high-precision CNS formulations. Whether you are a Government Tender Supplier for mental health in Africa or a B2B Pharma Marketplace partner in Latin America, we ensure secure, WHO-GMP compliant delivery.

Add to cart